Testing a study drug in healthy adults
This is an early-phase study testing a new drug called MK-1403 in healthy people. It helps doctors learn how the drug works in the body and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in good general health.
- Your body mass index (BMI) must be between 18 and 32.
- You must not have a history of cancer.
- You must not have a history of serious or multiple allergies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called MK-1406 in healthy volunteers to make sure it's safe before it can be studied in patients. If you're generally healthy, you could help advance medical research.
This study tests a new investigational medicine called MK-4082 to see how safe it is and how the body handles it in people who are overweight or have obesity. Participants will receive the study medicine in different forms, and the results may help guide future treatments for weight management.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This early-stage study tests whether a new oral drug (JMKX003801) is safe in healthy volunteers. It helps find the right dose and checks for side effects.
This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.
This trial tests a new medicine called MK-4082 in healthy people to see how safe it is and how the body handles it. It may help understand if the drug could be used for future treatments.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.